Synairgen (SNG) Competitors GBX 2 -1.75 (-46.60%) (As of 12/20/2024 12:01 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines SNG vs. COS, C4XD, DDDD, SAR, AREC, OKYO, OBI, OPTI, AOR, and RLMShould you be buying Synairgen stock or one of its competitors? The main competitors of Synairgen include Collagen Solutions plc (COS.L) (COS), C4X Discovery (C4XD), 4D pharma (DDDD), Sareum (SAR), Arecor Therapeutics (AREC), OKYO Pharma (OKYO), Ondine Biomedical (OBI), OptiBiotix Health (OPTI), AorTech International (AOR), and Realm Therapeutics (RLM). These companies are all part of the "biotechnology" industry. Synairgen vs. Collagen Solutions plc (COS.L) C4X Discovery 4D pharma Sareum Arecor Therapeutics OKYO Pharma Ondine Biomedical OptiBiotix Health AorTech International Realm Therapeutics Collagen Solutions plc (COS.L) (LON:COS) and Synairgen (LON:SNG) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, community ranking, valuation, profitability, earnings, institutional ownership, dividends and media sentiment. Does the MarketBeat Community prefer COS or SNG? Synairgen received 24 more outperform votes than Collagen Solutions plc (COS.L) when rated by MarketBeat users. However, 72.88% of users gave Collagen Solutions plc (COS.L) an outperform vote while only 56.46% of users gave Synairgen an outperform vote. CompanyUnderperformOutperformCollagen Solutions plc (COS.L)Outperform Votes12972.88% Underperform Votes4827.12% SynairgenOutperform Votes15356.46% Underperform Votes11843.54% Is COS or SNG more profitable? Collagen Solutions plc (COS.L)'s return on equity of 0.00% beat Synairgen's return on equity.Company Net Margins Return on Equity Return on Assets Collagen Solutions plc (COS.L)N/A N/A N/A Synairgen N/A -48.86%-30.58% Does the media prefer COS or SNG? In the previous week, Collagen Solutions plc (COS.L)'s average media sentiment score of 0.00 equaled Synairgen'saverage media sentiment score. Company Overall Sentiment Collagen Solutions plc (COS.L) Neutral Synairgen Neutral Which has better valuation & earnings, COS or SNG? Collagen Solutions plc (COS.L) has higher revenue and earnings than Synairgen. Synairgen is trading at a lower price-to-earnings ratio than Collagen Solutions plc (COS.L), indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCollagen Solutions plc (COS.L)£4.01M7.73N/A-£0.80-8.28Synairgen£79K50.98-£42.87M-£0.03-66.67 Do insiders & institutionals hold more shares of COS or SNG? 30.7% of Synairgen shares are owned by institutional investors. 3.2% of Synairgen shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummaryCollagen Solutions plc (COS.L) and Synairgen tied by winning 5 of the 10 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Synairgen News Delivered to You Automatically Sign up to receive the latest news and ratings for SNG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNG vs. The Competition Export to ExcelMetricSynairgenBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£4.03M£165.68M£5.14B£1.91BDividend Yield1.53%3.64%5.09%5.45%P/E Ratio-66.67115.5190.051,871.08Price / Sales50.9818,531.021,116.25393,610.87Price / Cash1.9012.8743.1028.67Price / Book0.088.594.782.81Net Income-£42.87M-£20.67M£120.31M£155.88M7 Day Performance-54.44%-1.05%-1.92%-2.02%1 Month Performance-56.80%174.77%13.65%21.69%1 Year Performance-69.72%134.18%28.34%29.83% Synairgen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNGSynairgenN/AGBX 2-46.6%N/A-70.1%£4.03M£79,000.00-66.6734Gap DownHigh Trading VolumeCOSCollagen Solutions plc (COS.L)N/AGBX 6.63flatN/A+0.0%£30.99M£4.01M-8.283,350C4XDC4X DiscoveryN/AN/AN/AN/A£30.27M£24.68M300.0049High Trading VolumeDDDD4D pharmaN/AGBX 16.66flatN/AN/A£30.05M£718,000.00-1.08106News CoverageSARSareumN/AGBX 260.0%N/A-51.7%£28.07M£47,204.00-433.333,211ARECArecor TherapeuticsN/AGBX 70-0.7%N/A-63.3%£26.43M£4.90M-251.7910Gap DownOKYOOKYO PharmaN/AGBX 1.40-24.3%N/AN/A£23.24MN/A-140.007News CoverageGap DownOBIOndine BiomedicalN/AGBX 8+5.3%N/A-6.2%£22.18M£1.63M-253.33N/AGap UpOPTIOptiBiotix HealthN/AGBX 22.60+6.6%N/A-26.9%£22.13M£1.26M-753.331High Trading VolumeAORAorTech InternationalN/AN/AN/AN/A£19.99M£539,000.00-33.383RLMRealm TherapeuticsN/AGBX 11.50flatN/AN/A£13.41M£501,919.00-0.66N/A Related Companies and Tools Related Companies Collagen Solutions plc (COS.L) Competitors C4X Discovery Competitors 4D pharma Competitors Sareum Competitors Arecor Therapeutics Competitors OKYO Pharma Competitors Ondine Biomedical Competitors OptiBiotix Health Competitors AorTech International Competitors Realm Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:SNG) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synairgen plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Synairgen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SNG Stock Alerts